Advertisement
YOU ARE HERE: LAT HomeCollectionsSonus Pharmaceuticals Inc
IN THE NEWS

Sonus Pharmaceuticals Inc

FEATURED ARTICLES
BUSINESS
February 23, 1993 | James M. Gomez / Times staff writer
Headquarters Move: Orange County, fast becoming a center for medical research, is home to yet another fledgling drug company. Sonus Pharmaceuticals Inc., which is in the first stages of research on a drug to be used with ultrasound procedures, has moved its 13-person headquarters from a crowded office in Los Angeles to bigger digs in Costa Mesa.
ARTICLES BY DATE
BUSINESS
February 23, 1993 | James M. Gomez / Times staff writer
Headquarters Move: Orange County, fast becoming a center for medical research, is home to yet another fledgling drug company. Sonus Pharmaceuticals Inc., which is in the first stages of research on a drug to be used with ultrasound procedures, has moved its 13-person headquarters from a crowded office in Los Angeles to bigger digs in Costa Mesa.
Advertisement
BUSINESS
April 22, 1997 | (Bloomberg News)
A federal judge temporarily blocked government approval of Molecular Biosystems Inc.'s newest heart-imaging agent. U.S. District Judge Paul L. Friedman ordered the Food and Drug Administration not to approve the product, known as FS069, until it reconsiders a challenge by rival companies that say the FDA is using the wrong classification system to evaluate the ultrasound imaging agent. At stake are U.S. sales that could reach $150 million a year for the product, according to analysts.
BUSINESS
January 6, 1998 | From Bloomberg News
Molecular Biosystems Inc. and Mallinckrodt Inc. said they won U.S. approval to sell the first of a new generation of imaging agents used with ultrasound procedures. The Food and Drug Administration approval for the product, called Optison, is key for San Diego-based Molecular Bio, which has been part of a legal struggle with Sonus Pharmaceuticals Inc. and other drug companies over how the FDA regulates imaging agents.
BUSINESS
November 11, 2004 | Leslie Earnest and Josh Friedman, Times Staff Writers
The hedge fund coming to the rescue of Wet Seal Inc. is one of the most active traders on Wall Street, a highflying outfit not exactly known for its expertise in selling clothes to teenage girls. That doesn't mean S.A.C. Capital Advisors is an unlikely savior for the Foothill Ranch retailer.
Los Angeles Times Articles
|